RELATED CONTENT
NEWS
- Novartis sees no 2012 revenue slippage despite Diovan and Tekturna
- Acquisitions pave the way to the patent cliff
- 2012 Scrip 100 Preview: Base jumping for pharma – a slower descent from the patent cliff?
- UCB execs take positive stance as big pharma peers wail about difficult environment
ANALYSIS
Other Informa Analysis
EVENTS
07 June 2012
The Rembrandt Hotel, London
12 June 2012
Annecy, France
18 June 2012
Boston Convention & Exhibition Center, Boston, MA
JOB OF THE WEEK

Section Head (m/f)
DRA International/CIS Section

Section Head (m/f)
DRA International/CIS Section

